Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.40 -0.09 (-2.58%)
As of: Oct 1, 2026 · 2:25 PM EDT

Galmed Pharmaceuticals (EOCN) Accumulated Depreciation (2018 - 2024)

Updated

Galmed Pharmaceuticals (EOCN) posted Accumulated Depreciation of $1.1 million for Q4 2024, up 8.2% from $1.02 million a year earlier.

Analysis

Galmed Pharmaceuticals (EOCN) Accumulated Depreciation (2018 - 2024) Analysis & Trends

Since Q4 2018, Galmed Pharmaceuticals has reported Accumulated Depreciation for 7 quarters.

  • Annual Accumulated Depreciation has increased for six consecutive years, with a five-year compound annual growth rate of 4.0% (FY2019 to FY2024).
  • In prior years, Galmed Pharmaceuticals' Accumulated Depreciation was $1.02 million in FY2023 (+3.1%), $988,000 in FY2022 (+3.2%), $957,000 in FY2021 (+4.5%) and $916,000 in FY2020 (+1.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Galmed Pharmaceuticals 406,071.97 406,071.97 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.10 Mn
Dec 31, 2023 1.02 Mn
Dec 31, 2022 988,000.00
Dec 31, 2021 957,000.00
Dec 31, 2020 916,000.00
Dec 31, 2019 907,000.00
Dec 31, 2018 872,000.00
API Access

Galmed Pharmaceuticals Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=EOCN&period=max&api_key=YOUR_API_KEY